News 08.06.2020 Zurich, Switzerland, June 4 2020 – CUTISS AG, an innovative Swiss Life Science Company aiming to provide patients that suffer from large and deep skin defects with an automatically produced, personalized skin tissue therapy, denovoSkin™, today announced it has successfully secured its series B financing round. Funds raised so far...
News 05.06.2020 Schlieren, Switzerland – 4 June 2020 – Memo Therapeutics AG (“MTx”), an innovator in the field of antibody discovery and immune repertoire analysis, today announces that it has identified several SARS-CoV-2-specific virus-neutralizing antibodies with the potential for development as a COVID-19 immunotherapy. MTx’s DROPZYLLA® platform isolated ultra-rare and highly potent...
Events, Internal events
Event date: 10.06.2020
Wed, Jun 10, 2020 8:30 AM - 9:30 AM CEST
Registration: https://register.gotowebinar.com/register/1773650101719810572
Methods from the fields of Machine Learning and Artificial Intelligence have been applied successfully in many different domains and industries. The health sector is no exception to this. The digitisation of medical records and diagnostic data along with the increasing...
News 26.05.2020 Zurich-Schlieren, May 26, 2020. Proteomedix, the Swiss cancer diagnostics company is pleased to announce the appointment of Dr Maurizio Ballerini, MD as VP Market Development EMEA and Dr Helene Peyro Saint-Paul, MD, as Medical Advisor effective June 1, 2020. These accomplished executives bring a wealth of industry expertise to the...
News 19.05.2020 Zurich-Schlieren, Switzerland, May 19, 2020. Proteomedix, the Swiss cancer diagnostics company announces today the publication of the analytical performance results of Proclarix, Proteomedix lead product for improved prostate cancer diagnostics in the peer-reviewed journal PLOS ONE. The report published today highlights the analytical performance of the two CE-IVD assays that measure...